SCHEMBL23917231

SCHEMBL23917231

Nc1ncnc2[nH]nc(-c3cc(O)c(Cl)c(C(F)(F)F)c3)c12

nearest known ligand 0.36

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SRC P12931 14/20 0.36
PIK3CD O00329 13/20 0.36
PIK3CA P42336 13/20 0.36
PIK3CB P42338 13/20 0.36
PIK3CG P48736 13/20 0.36
PRKDC P78527 13/20 0.36
ABL1 P00519 13/20 0.36
EGFR P00533 12/20 0.36
HCK P08631 11/20 0.36
KDR P35968 11/20 0.36
MTOR P42345 11/20 0.36
PI4KB Q9UBF8 10/20 0.36
EPHB4 P54760 10/20 0.36
RIPK1 Q13546 1/20 0.34
GYS1 P13807 2/20 0.31
RET P07949 2/20 0.31
LCK P06239 1/20 0.31
PRKCA P17252 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16665741 0.87 PIK3CD (0.36) SRCPIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL23917236 0.84 PIK3CD (0.39) SRCPIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL16655157 0.76 PIK3CD (0.47) SRCPIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL21467104 0.76 PIK3CD (0.54) SRCPIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL21467053 0.74 PIK3CG (0.52) SRCPIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL20093476 0.74 VRK1 (0.41) SRCPIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL11928101 0.74 PIK3CD (0.56) SRCPIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL16065725 0.72 PIK3CD (0.53) SRCPIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL20640210 0.71 CFTR (0.36) SRCPIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL16665713 0.71 PIK3CD (0.36) SRCPIK3CDPIK3CAPIK3CBPIK3CG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210317140-A1 Heterocyclic Compounds and Methods of Use MEDIVATION TECHNOLOGIES, INC. (US) 2021-10-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210317140-A1 Heterocyclic Compounds and Methods of Use BTK, PIK3CD, PIK3CB SRC 92/4885PIK3CD 2/4885PIK3CA 6/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.